Global Liver-specific Assays Service Market Growth (Status and Outlook) 2023-2029

Global Liver-specific Assays Service Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Liver-specific Assays Service Industry Forecast” looks at past sales and reviews total world Liver-specific Assays Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Liver-specific Assays Service sales for 2023 through 2029. With Liver-specific Assays Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liver-specific Assays Service industry.

This Insight Report provides a comprehensive analysis of the global Liver-specific Assays Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liver-specific Assays Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liver-specific Assays Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liver-specific Assays Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liver-specific Assays Service.

The global Liver-specific Assays Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Liver-specific Assays Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Liver-specific Assays Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Liver-specific Assays Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Liver-specific Assays Service players cover Solvo Biotechnology, Cyprotex, MB Biosciences, Visikol and InSphero, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Liver-specific Assays Service market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Hepatocyte Uptake Assay
Hepatocyte clearance assay
Hepatocyte Biliary Excretion Assay
Hepatocyte Functional polarity assay
Hepatic phospholipidosis assay
Hepatic cholestasis assay
Other

Segmentation by application
Laboratory
Hospital

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Solvo Biotechnology
Cyprotex
MB Biosciences
Visikol
InSphero

Please note: The report will take approximately 2 business days to prepare and deliver.